Landos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for ...

Retrieved on: 2021-06-14 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Landos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for .... View article details on hiswai:

Excerpt

BLACKSBURG, Va., June 14, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a late-clinical-stage biopharmaceutical ...

Article found on: www.globenewswire.com